InsidersTradesSigma
申报总数
公司
▲ 买入（55 笔）
▼ 卖出（20 笔）
内部人交易记录
首席执行官已披露买入
55
已披露卖出
20
T+90 胜率
67%
T+90 平均收益
+15.2%
基于 12 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Explore the complete record of transactions filed by Bvf Partners l P/il, Managing Director. Insider active across 22 companies, notably Rain Therapeutics Inc.. Cumulatively, 97 disclosures have been logged. Breakdown: 55 buys · 20 sells. Total volume traded: €446.6m. History available since 23 April 2021. The latest transaction was filed on 31 March 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Bvf Partners l P/il
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报97 总计
3,635,758 股Common Stock, $0.0075 par value per shareSEC:0000921895-26-001823:0
2,773,545 股Common Stock, $0.0075 par value per shareSEC:0000921895-26-001823:1
412,000 股Common Stock, $0.0075 par value per shareSEC:0000921895-26-001823:2
772,000 股Common Stock, $0.0075 par value per shareSEC:0000921895-26-001823:3
837,914 股Common Stock, $0.0001 par valueSEC:0000921895-26-001688:0
627,597 股Common Stock, $0.0001 par valueSEC:0000921895-26-001688:1
113,289 股Common Stock, $0.0001 par valueSEC:0000921895-26-001688:2
51,858 股Common Stock, $0.0001 par valueSEC:0000921895-26-001688:3
1,932,354 股@ US$16.7919.3% 占其流量Class A Ordinary Shares, $0.0001 par valueSEC:0000921895-26-000895:0
1,569,116 股@ US$16.7915.7% 占其流量Class A Ordinary Shares, $0.0001 par valueSEC:0000921895-26-000895:1
248,530 股@ US$16.792.5% 占其流量Class A Ordinary Shares, $0.0001 par valueSEC:0000921895-26-000895:2
5,309,432 股Common Shares, no par valueSEC:0000921895-26-000173:0
6,194,145 股Common StockSEC:0000921895-25-002742:0
4,726,743 股Common StockSEC:0000921895-25-002742:1
560,797 股Common StockSEC:0000921895-25-002742:2
1,481,634 股100.0% 占其流量Common StockSEC:0000921895-25-002133:0
142,604 股@ US$44.0010.8% 占其流量Common Stock, $0.0001 par valueSEC:0000921895-25-001910:0
标准退出：2025年9月28日 (T+90)
115,783 股@ US$44.008.7% 占其流量Common Stock, $0.0001 par valueSEC:0000921895-25-001910:1
标准退出：2025年9月28日 (T+90)
58,780 股@ US$44.004.4% 占其流量Common Stock, $0.0001 par valueSEC:0000921895-25-001910:2
标准退出：2025年9月28日 (T+90)
657,308 股Common StockSEC:0000921895-25-001784:0
127,407 股@ US$27.1015.9% 占其流量Common Stock, $0.0075 par value per shareSEC:0000921895-25-001602:0
8,679,726 股Common Stock, $0.001 par valueSEC:0000921895-25-001590:0
339,679 股@ US$26.1043.9% 占其流量Common Stock, $0.0075 par value per shareSEC:0000921895-25-000177:0
85,776 股@ US$26.1011.1% 占其流量Common Stock, $0.0075 par value per shareSEC:0000921895-25-000177:1
75,287 股@ US$26.109.7% 占其流量Common Stock, $0.0075 par value per shareSEC:0000921895-25-000177:2
97 条申报中的 25 条
About Bvf Partners l P/il
BVF PARTNERS L P/IL is Managing Director and has filed 93 disclosures in total. In the 93 sampled filings, the transactions span 2016-01-11 to 2026-06-26, with buys of EUR 117456479 and sells of EUR 329188662. The companies mentioned include Kymera Therapeutics, Inc., CTI Biopharma CORP, Olema Pharmaceuticals, Inc., Rain Therapeutics Inc., XOMA Corp, and Repare Therapeutics Inc.
